Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones

Authors

Chunzhang Yang
Shervin Rahimpour
Jie Lu
Karel Pacak
Barbara Ikejiri
Roscoe O. Brady, George Washington UniversityFollow
Zhengping Zhuang

Document Type

Journal Article

Publication Date

1-15-2013

Journal

Proceedings of the National Academy of Sciences (USA)

Volume

Volume 110, Issue 3

Inclusive Pages

966-971

Keywords

Gaucher Disease--drug therapy; Gaucher Disease--enzymology; Glucosylceramidase--metabolism; Histone Deacetylase Inhibitors--pharmacology; Molecular Chaperones--metabolism

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Yang, C., Rahimpour, S., Lu, J., Pacak, K., Ikejiri, B. et al. (2013). Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones. Proceedings of the National Academy of Sciences, 110(3), 966-971.

Peer Reviewed

1

Open Access

1